胸外科医师学会新型主动脉手术死亡与并发症风险模型的建立
基于STS ACSD 2017年扩展数据,纳入2017至2021年905家医院24051例非急诊孤立升主动脉瘤修复患者,建立首个经验证的升主动脉手术风险模型。模型预测手术死亡、30天主要并发症及复合结局,调整后C统计量分别为0.74、0.67和0.67。
要点
- 模型覆盖升主动脉瘤开放或钳夹远端吻合修复,含根部或瓣膜置换病例。
- 手术死亡率为1.9%,12.2%患者发生主要并发症,卒中发生率2.4%。
- 既往卒中和循环停跳与新发卒中相关,遗传性主动脉病与较低死亡率相关。
核心结论
- 基于STS ACSD建立了预测升主动脉瘤术后死亡与并发症的新风险模型,并识别出结局好坏的相关预测因素。
研究设计与样本
- 回顾性多中心队列研究,纳入2017至2021年905家医院24051例非急诊孤立升主动脉瘤修复患者。
- 模型结局包括手术死亡、30天主要并发症(心脏再手术、深部胸骨伤口感染、卒中、延长通气、肾衰竭)及复合结局,通过区分度与校准度评价。
主要发现
- 手术死亡率为1.9%,12.2%患者发生主要并发症,卒中发生率为2.4%。
- 循环停跳在7316例(30.4%)中实施。
- 调整后C统计量:死亡模型0.74,并发症模型0.67,复合结局模型0.67。
- 既往卒中和循环停跳与新发卒中相关,遗传性主动脉病与较低死亡率相关。
关键数值与推荐
- 手术类型包括8913例主动脉根部置换、2135例保留瓣膜根部置换、7545例升主动脉置换联合主动脉瓣置换、5458例升主动脉置换。
- 调整后C统计量死亡0.74、并发症0.67、复合结局0.67。
临床怎么用
- 可用于升主动脉瘤手术患者术前风险分层与咨询,辅助识别高危患者并优化围术期管理。
局限性
- 模型仅针对非急诊孤立升主动脉瘤修复,不涵盖急诊或其他主动脉手术类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS ACSD) was expanded in 2017 to include more granular detail on thoracic aortic surgeries. We describe the first validated risk model in thoracic aortic surgery from the STS ACSD. METHODS: The study population consisted of patients undergoing nonemergent isolated ascending aortic aneurysm repair by open or clamped distal anastomoses, including those requiring aortic root or valve replacement. Model outcomes included operative mortality, 30-day major morbidity (cardiac reoperation, deep sternal wound infection, stroke, prolonged ventilation, renal failure), and a composite of both. To select the predictors, univariate associations and clinical face validity of models were examined. Models were evaluated by their ability to distinguish between patients with and without specific outcomes (discrimination) and their predictive accuracy (calibration). RESULTS: Between 2017 and 2021, 24,051 eligible patients underwent ascending aortic aneurysm surgery at 905 hospitals. Procedures included 8913 aortic root replacements, 2135 valve-sparing root replacements, 7545 ascending aortic replacements with aortic valve replacement, and 5458 ascending aortic replacements. Circulatory arrest was performed in 7316 (30.4%) cases. Operative mortality was 1.9%, and 12.2% of patients experienced major morbidity including 2.4% incidence of stroke. The adjusted C statistics for the model were 0.74, 0.67, and 0.67 for mortality, morbidity, and the composite, respectively. Previous stroke and circulatory arrest were associated with new stroke. Genetic aortopathy was associated with less mortality. CONCLUSIONS: A new STS ACSD risk model to predict mortality and morbidity after ascending aneurysm surgery has been developed, and predictors of better and worse outcomes have been identified.
引用
- Desai ND, Vekstein A, Grau-Sepulveda M, et al. Development of a Novel Society of Thoracic Surgeons Aortic Surgery Mortality and Morbidity Risk Model. Ann Thorac Surg. 2024. PMID: 39366649. doi:10.1016/j.athoracsur.2024.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。